[3,4-Dihydroxyphenylacetic acid (DOPAC)].
Sasaki
Midori
M
Internal Medicine III, School of Medicine, Fukushima Medical University.
Sanada
Hironobu
H
D015102:3,4-Dihydroxyphenylacetic Acid / Q000032:analysis*; D000224:Addison Disease / Q000175:diagnosis; D000310:Adrenal Gland Neoplasms / Q000175:diagnosis; D000544:Alzheimer Disease / Q000175:diagnosis; D015415:Biomarkers / Q000032:analysis; D002851:Chromatography, High Pressure Liquid; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D009447:Neuroblastoma / Q000175:diagnosis; D010300:Parkinson Disease / Q000175:diagnosis; D010673:Pheochromocytoma / Q000175:diagnosis; D012016:Reference Values; D013048:Specimen Handling
D015415:Biomarkers; D015102:3,4-Dihydroxyphenylacetic Acid